Michael Stern Parkinsons Fdtn is categorized under Medical Research in New York City, NY and active since 2001.
Michael Stern Parkinsons Fdtn was established in 2001, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 541720 by the NAICS.
If you are seeking more information, feel free to contact Margaret Stern at the company’s single location by writing to 1115 Broadway Floor 12, New York City, New York NY 10010 or by phoning (646) 381-5144. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Michael Stern Parkinsons Fdtn |
| Contact Person: | Margaret Stern |
| Address: | 1115 Broadway Floor 12, New York City, New York 10010 |
| Phone Number: | (646) 381-5144 |
| Website Address: | alzinfo.org |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2001 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Medical Research |
| SIC Code: | 8733 |
| NAICS Code: | 541720 |
| Share This Business: |
Michael Stern Parkinsons Fdtn was started in 2001 to provide professional Medical Research under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Margaret Stern for inquiries that concern Michael Stern Parkinsons Fdtn by calling the company number (646) 381-5144, as your correspondence is most welcome. Additionally, the physical location of the single location of Michael Stern Parkinsons Fdtn can be found at the coordinates 40.742836,-73.989364 as well as the street address 1115 Broadway Floor 12 in New York City, New York 10010.
For its online presence, you may visit Michael Stern Parkinsons Fdtn’s website at alzinfo.org and engage with its social media outlets through on Twitter and on Facebook.